Exosomes: key players in cancer and potential therapeutic strategy
2020 · Signal Transduction and Targeted Therapy · 1,156 citations
https://doi.org/10.1038/s41392-020-00261-0
Y
Yangzhou Su
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
1.3K
Citations
3
h-index
2
i10-index
Yangzhou Su is an academic researcher from Van Andel Institute. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Head and Neck Cancer Studies & MicroRNA in disease regulation. The author has an h-index of 3, co-authored 7 publications.
ORCID: 0009-0002-7820-7100Papers by this author
worksThe role of cell‐penetrating peptides in potential anti‐cancer therapy
2022 · Clinical and Translational Medicine · 126 citations
https://doi.org/10.1002/ctm2.822
Expression of ENL YEATS domain tumor mutations in nephrogenic or stromal lineage impairs kidney development
2025 · Nature Communications · 0 citations
https://doi.org/10.1038/s41467-025-57926-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat